Find out more →

INVESTING IN LIFE CHANGING SCIENCE

Discover more

Our Portfolio

With a focus on late pre-clinical to clinical stage ventures and covering a diversified range of therapeutic areas, we partner with the most ambitious scientists and entrepreneurs to build companies around game-changing life science innovation.

View full portfolio

Video

Team

Experienced and collaborative team, with deep industry and scientific expertise.

Meet the team

Laura Craig

Investor Relations Officer

Jade Fletcher

Financial Controller

Roy Bartel-Taverner, MD

Analyst

Tassos Konstantinou

Managing Director

Tom Davidson

Finance Director

Felix Breyer, PhD

Associate

Robert Lyne

CEO

Investors

Public market access to revolutionary medical innovation

Find the latest share price, presentations, events and regulatory announcements here

Visit Investor Centre

Share price

Latest News

Updates from Arix and our porfolio companies.